These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27611656)

  • 1. Chromogranin A as biomarker in diabetes.
    Broedbaek K; Hilsted L
    Biomark Med; 2016 Nov; 10(11):1181-1189. PubMed ID: 27611656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of chromogranin-A and its derived peptide, WE-14 in the development of type 1 diabetes mellitus].
    Herold Z; Nagy P; Patócs A; Somogyi A
    Orv Hetil; 2015 Feb; 156(5):163-70. PubMed ID: 25618857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogranin Serves as Novel Biomarker of Endocrine and Gastric Autoimmunity.
    Ebert A; König J; Frommer L; Schuppan D; Kahaly GJ
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.
    Corti A; Marcucci F; Bachetti T
    Pflugers Arch; 2018 Jan; 470(1):199-210. PubMed ID: 29018988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromogranin A and its role in the pathogenesis of diabetes mellitus.
    Herold Z; Doleschall M; Kovesdi A; Patocs A; Somogyi A
    Endokrynol Pol; 2018; 69(5):598-610. PubMed ID: 30074235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
    Mahata SK; Corti A
    Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Roles of Chromogranins and Derived Polypeptides in Atherosclerosis, Diabetes, and Coronary Heart Disease.
    Watanabe T
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Critical Approach to Clinical Biochemistry of Chromogranin A.
    Bottoni P; De Michele T; Scatena R
    Adv Exp Med Biol; 2015; 867():317-23. PubMed ID: 26530374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A and derived peptides in health and disease.
    Loh YP; Cheng Y; Mahata SK; Corti A; Tota B
    J Mol Neurosci; 2012 Oct; 48(2):347-56. PubMed ID: 22388654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
    Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
    Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin-A: a multifaceted cardiovascular role in health and disease.
    Angelone T; Mazza R; Cerra MC
    Curr Med Chem; 2012; 19(24):4042-50. PubMed ID: 22834795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A: any relevance in neuroendocrine tumors?
    Kidd M; Bodei L; Modlin IM
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):28-37. PubMed ID: 26627724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and function of granin proteins in diabetes mellitus.
    Herold Z; Doleschall M; Somogyi A
    World J Diabetes; 2021 Jul; 12(7):1081-1092. PubMed ID: 34326956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A in gastrinomas: Promises and pitfalls.
    Rehfeld JF
    Clin Chim Acta; 2015 Jun; 446():15-20. PubMed ID: 25861845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin-A production and fragmentation in patients with Takayasu arteritis.
    Tombetti E; Colombo B; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bozzolo EP; Tombolini E; Benedetti G; Godi C; Lanzani C; Rovere-Querini P; Del Maschio A; Ambrosi A; De Cobelli F; Sabbadini MG; Baldissera E; Corti A; Manfredi AA
    Arthritis Res Ther; 2016 Aug; 18():187. PubMed ID: 27531191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.
    Takiyyuddin MA; Cervenka JH; Pandian MR; Stuenkel CA; Neumann HP; O'Connor DT
    J Clin Endocrinol Metab; 1990 Aug; 71(2):360-9. PubMed ID: 2116438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the chromogranin A post-translational cleavage product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries.
    Lloyd RV; Jin L; Qian X; Scheithauer BW; Young WF; Davis DH
    Am J Pathol; 1995 May; 146(5):1188-98. PubMed ID: 7747813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).
    Jitpean S; Stridsberg M; Pettersson A; Höglund OV; Holst BS; Hagman R
    BMC Vet Res; 2015 Jan; 11():14. PubMed ID: 25636335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
    Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
    Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.